Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial

This study has been completed.
Information provided by:
Tibotec Pharmaceuticals, Ireland Identifier:
First received: May 18, 2005
Last updated: May 18, 2011
Last verified: April 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2007
  Estimated Primary Completion Date: No date given